Increased Expression Of SOX2 Predicts A Poor Prognosis And Promotes Malignant Phenotypes In Upper Tract Urothelial Carcinoma.
Zhengqing BaoYonghao ZhanShiming HeYifan LiBao GuanQun HeXinyu YangXuesong LiDong FangLiqun ZhouPublished in: Cancer management and research (2019)
SOX2 is an independent prognostic marker of poor DFS and CSS in UTUC patients who have undergone RNU. Moreover, these data suggest that SOX2 may be a promising therapeutic target in UTUC.